Concepedia

Michelle L. O’Donoghue

ML

Statistics

Publications

82

Citations

8.9K

H-Index

45

Active since

2005

Affiliations

Brigham and Women's Hospital(Current)

Thrombolysis in Myocardial Infarction Study Group

Harvard University

Massachusetts General Hospital

Amgen (United States)

Michelle L. O’Donoghue is an author at Brigham and Women's Hospital specializing in medicine, cardiovascular disease, and pharmacology.

ORCID

Top concepts

Publications per year

2005–2025

82

Publications

82

Lipoprotein(a), PCSK9 Inhibition, and Cardiovascular Risk

Michelle L. O’Donoghue, Sergio Fazio, Robert P. Giugliano et al. · Circulation · 2019 · 895 citations · Full text

Prasugrel Compared With High Loading- and Maintenance-Dose Clopidogrel in Patients With Planned Percutaneous Coronary Intervention

Stephen D. Wiviott, Dietmar Trenk, Andrew L. Frelinger et al. · Circulation · 2007 · 874 citations

Measurement of the Interleukin Family Member ST2 in Patients With Acute Dyspnea

James L. Januzzi, W. Frank Peacock, Alan S. Maisel et al. · Journal of the American College of Cardiology · 2007 · 507 citations

, , +8

Small Interfering RNA to Reduce Lipoprotein(a) in Cardiovascular Disease

Michelle L. O’Donoghue, Robert S. Rosenson, Bariş Gencer et al. · New England Journal of Medicine · 2022 · 451 citations · Full text

Effect of Darapladib on Major Coronary Events After an Acute Coronary Syndrome

Michelle L. O’Donoghue, Eugene Braunwald, Harvey D. White et al. · JAMA · 2014 · 445 citations

Rows per page

1–5 of 82